naclaitesque
Antibodies Assay Kits Biology Cells cDNA Clia Kits Culture Cells Devices DNA DNA Templates Elisa Kits Enzymes Equipments Exosomes Gels Isotypes Medium & Serums NATtrol Panel Particles PCR Pcr Kits Peptides Reagents Recombinant Proteins Ria Kits RNA Test Kits Vector & Virus Western Blot
August 26, 2020

Cross-Couplings between Alkyl Halides and Grignard Reagents

By Danielle

Cobalt-Catalyzed Cross-Couplings between Alkyl Halides and Grignard Reagents

ConspectusMetal-catalyzed cross-couplings have emerged as necessary devices for the event of C-C bonds. The identification of setting pleasant catalytic packages along with huge substrate scope made these cross-couplings key reactions to entry useful molecules ranging from provides, agrochemicals to vigorous pharmaceutical parts.
They have been an increasing number of built-in in retrosynthetic plans, allowing shorter and genuine route enchancment. Palladium-catalyzed cross-couplings nonetheless largely rule the sphere, with essentially the most well-liked reactions in industrial processes being the Suzuki and Sonogashira couplings.
Nonetheless, the intensive use of palladium complexes raises plenty of points equivalent to limited belongings, excessiveprice, environmental affect, and frequent wantfor fashionable ligands. As a consequence, utilizing nonprecious and low price metallic catalysts has appeared as a model new horizon in cross-coupling enchancment.
Over the previous three a few years, a rising curiosity has thus been devoted to Fe-, Co-, Cu-, or Ni-catalyzed cross-couplings. Their pure abundance makes them cost-effective, allowing the conception of additional sustainable and cheaper chemical processes, significantly for large-scale manufacturing of vigorous molecules.
  • Together with these economical and environmental considerations, the 3d metallic catalysts moreover exhibit complementary reactivity with palladium complexes, facilitating utilizing alkyl halide companions attributable to the decrease of β-elimination side reactions.
  • Particularly, by using cobalt catalysts, fairly just a few cross-couplings between alkyl halides and organometallics have been described.
  • Nonetheless, cobalt catalysis nonetheless stays far behind palladium catalysis with regards to fame and functions, and the enlargement of the substrate scope along with the occasion of easy and durable catalytic packages stays an needed drawback.
  • In 2012, our group entered the cobalt catalysis space by rising a cobalt-catalyzed cross-coupling between C-bromo glycosides and Grignard reagents. The generality of the coupling allowed the preparation of a wide range of useful C-aryl and C-vinyl glycoside establishing blocks.
  • We then centered on the functionalization of saturated N-heterocycles, and various halo-azetidines, -pyrrolidines, and -piperidines had been effectively reacted with aryl and alkenyl Grignard reagents beneath cobalt catalysis.
  • With the goal of creating prepared useful α-aryl amides, a cobalt-catalyzed cross-coupling utilized to α-bromo amides was studied after which extended to α-bromo lactams.
  • These days, we moreover reported an setting pleasant and regular cross-coupling involving cyclopropyl- and cyclobutyl-magnesium bromides. This technique permits the alkylation of functionalized small strained rings by a wide range of main and secondary alkyl halides.
gentaur.com

gentaur

EZ-DNA Reagents
BS8202 100preps
EUR 88.06

EZ-DNA Reagents
SK8201 100preps
EUR 93.5

BI 6727
2222-1
EUR 120

BI 6727
2222-5
EUR 327

BI-2536
2370-25
EUR 523

BI-2536
2370-5
EUR 175

BI-D1870
1924-1
EUR 142

BI-D1870
1924-5
EUR 370

BI-78D3
B1686-25
EUR 528

BI-78D3
B1686-5
EUR 175

BI-7273
B1879-25
EUR 892

BI-7273
B1879-5
EUR 262

BI-9564
B1880-25
EUR 756

BI-9564
B1880-5
EUR 229

BI-409306
B2377-25
EUR 756

BI-409306
B2377-5
EUR 229

BI-9627
HY-18071 5mg
EUR 291

BI 224436
HY-18595 5mg
EUR 533

(±)-BI-D
HY-18601 100mg
EUR 2943

BI-847325
HY-18955 100mg
EUR 1262

BI 2536
HY-50698 100mg
EUR 1229

BI-78D3
HY-10366 25mg
EUR 349

BI-6C9
HY-103661 50mg
EUR 1083

BI-D1870
HY-10510 2mg
EUR 147

BI-882370
HY-107779 100mg
EUR 1164

BI-3802
HY-108705 10mg
EUR 911

BI-3812
HY-111381 25mg
EUR 1772

BI-3663
HY-111546 1mg
EUR 681

BI-749327
HY-111925 100mg
EUR 3092

BI-409306
HY-112831 50mg
EUR 2058

BI-671800
HY-114141 100mg
EUR 3092

BI-1347
HY-120350 10mM/1mL
EUR 176

BI-167107
HY-121251 100mg
EUR 2633

BI-4464
HY-124625 10mg
EUR 911

BI 01383298
HY-124738 10mM/1mL
EUR 163

BI-4020
HY-129550 10mg
EUR 681

BI-7273
HY-100351 50mg
EUR 877

BI-9564
HY-100352 200mg
EUR 2254

BI 689648
HY-101217 25mg
EUR 2116

BI 78D3
B9011-10 10 mg
EUR 216
Description: BI-78D3 is a substrate competitive inhibitor of JNK inhibitor [2].JNK is a member of the MAPK family. JNK is a stress-activated protein kinase that modulates pathways implicated in a variety of disease states.

BI 78D3
B9011-100 100 mg
EUR 1094
Description: BI-78D3 is a substrate competitive inhibitor of JNK inhibitor [2].JNK is a member of the MAPK family. JNK is a stress-activated protein kinase that modulates pathways implicated in a variety of disease states.

BI 78D3
B9011-25 25 mg
EUR 412
Description: BI-78D3 is a substrate competitive inhibitor of JNK inhibitor [2].JNK is a member of the MAPK family. JNK is a stress-activated protein kinase that modulates pathways implicated in a variety of disease states.

BI 78D3
B9011-5 5 mg
EUR 161
Description: BI-78D3 is a substrate competitive inhibitor of JNK inhibitor [2].JNK is a member of the MAPK family. JNK is a stress-activated protein kinase that modulates pathways implicated in a variety of disease states.

BI 78D3
B9011-5.1 10 mM (in 1mL DMSO)
EUR 183
Description: BI-78D3 is a substrate competitive inhibitor of JNK inhibitor [2].JNK is a member of the MAPK family. JNK is a stress-activated protein kinase that modulates pathways implicated in a variety of disease states.

BI 78D3
B9011-50 50 mg
EUR 676
Description: BI-78D3 is a substrate competitive inhibitor of JNK inhibitor [2].JNK is a member of the MAPK family. JNK is a stress-activated protein kinase that modulates pathways implicated in a variety of disease states.

BI 2536
A3965-10 10 mg
EUR 224
Description: BI 2536 is a potent, ATP-competitive, well tolerated and highly specific human polo-like kinase 1 (PLK1) inhibitor with IC value of 0.83 nM, which shows 1000-fold selectivity against other kinases [1].

BI 2536
A3965-5 5 mg
EUR 148
Description: BI 2536 is a potent, ATP-competitive, well tolerated and highly specific human polo-like kinase 1 (PLK1) inhibitor with IC value of 0.83 nM, which shows 1000-fold selectivity against other kinases [1].

BI 2536
A3965-5.1 10 mM (in 1mL DMSO)
EUR 195
Description: BI 2536 is a potent, ATP-competitive, well tolerated and highly specific human polo-like kinase 1 (PLK1) inhibitor with IC value of 0.83 nM, which shows 1000-fold selectivity against other kinases [1].

BI 2536
A3965-50 50 mg
EUR 595
Description: BI 2536 is a potent, ATP-competitive, well tolerated and highly specific human polo-like kinase 1 (PLK1) inhibitor with IC value of 0.83 nM, which shows 1000-fold selectivity against other kinases [1].

BI 2536
A3965-S Evaluation Sample
EUR 81
Description: BI 2536 is a potent, ATP-competitive, well tolerated and highly specific human polo-like kinase 1 (PLK1) inhibitor with IC value of 0.83 nM, which shows 1000-fold selectivity against other kinases [1].

BI 6015
B5668-10 10 mg
EUR 179
Description: BI 6015 is an antagonist of hepatocyte nuclear factor 4? [1]. Hepatocyte nuclear factor 4? (HNF4?) is a nuclear receptor and regulates gene expression in enterocytes, hepatocytes and pancreatic ? cells [1]. BI 6015 is a HNF4? antagonist.

BI 6015
B5668-5 5 mg
EUR 118
Description: BI 6015 is an antagonist of hepatocyte nuclear factor 4? [1]. Hepatocyte nuclear factor 4? (HNF4?) is a nuclear receptor and regulates gene expression in enterocytes, hepatocytes and pancreatic ? cells [1]. BI 6015 is a HNF4? antagonist.

BI 6015
B5668-50 50 mg
EUR 595
Description: BI 6015 is an antagonist of hepatocyte nuclear factor 4? [1]. Hepatocyte nuclear factor 4? (HNF4?) is a nuclear receptor and regulates gene expression in enterocytes, hepatocytes and pancreatic ? cells [1]. BI 6015 is a HNF4? antagonist.

BI-847325
B6014-1 1 mg
EUR 132
Description: BI 847325 is a dual inhibitor of Ras-mitogen-activated protein kinase kinases (MEK) and Aurora kinases [1,2]. BI 847325 inhibits MEK1 and MEK2 with IC50 values of 25 and 4 nM, respectively.

BI-847325
B6014-5 5 mg
EUR 242
Description: BI 847325 is a dual inhibitor of Ras-mitogen-activated protein kinase kinases (MEK) and Aurora kinases [1,2]. BI 847325 inhibits MEK1 and MEK2 with IC50 values of 25 and 4 nM, respectively.

BI-9564
B6184-1 1 mg
EUR 109
Description: IC50: 75 nM and 3.4 ?M for BRD9 and BRD7 bromodomains, respectivelyBI-9564 is a BRD9/7 specific inhibitor.BRD7 and BRD9 are two important members of the bromodomain family protein.

BI-9564
B6184-10 10 mg
EUR 293
Description: IC50: 75 nM and 3.4 ?M for BRD9 and BRD7 bromodomains, respectivelyBI-9564 is a BRD9/7 specific inhibitor.BRD7 and BRD9 are two important members of the bromodomain family protein.

BI-D1870
B2227-10 10 mg
EUR 270
Description: BI-D1870 is a cell-permeable inhibitor of the p90 RSK isoforms with IC50 values of 31nM, 24nM, 18nM and 15nM for RSK1, RSK2, RSK3 and RSK4 respectively [1].BI-D1870 is a derivative of dihydropteridinone and found to be a remarkably specific inhibitor of RSK isoforms.

BI-D1870
B2227-5 5 mg
EUR 189
Description: BI-D1870 is a cell-permeable inhibitor of the p90 RSK isoforms with IC50 values of 31nM, 24nM, 18nM and 15nM for RSK1, RSK2, RSK3 and RSK4 respectively [1].BI-D1870 is a derivative of dihydropteridinone and found to be a remarkably specific inhibitor of RSK isoforms.

BI-D1870
B2227-5.1 10 mM (in 1mL DMSO)
EUR 235
Description: BI-D1870 is a cell-permeable inhibitor of the p90 RSK isoforms with IC50 values of 31nM, 24nM, 18nM and 15nM for RSK1, RSK2, RSK3 and RSK4 respectively [1].BI-D1870 is a derivative of dihydropteridinone and found to be a remarkably specific inhibitor of RSK isoforms.

BI-D1870
B2227-50 50 mg
EUR 595
Description: BI-D1870 is a cell-permeable inhibitor of the p90 RSK isoforms with IC50 values of 31nM, 24nM, 18nM and 15nM for RSK1, RSK2, RSK3 and RSK4 respectively [1].BI-D1870 is a derivative of dihydropteridinone and found to be a remarkably specific inhibitor of RSK isoforms.

BI-7273
B6196-25 25 mg
EUR 437
Description: IC50: 19 and 117 nM for BRD9 and BRD7, respectively.BI-7273 is a BRD9 bromodomain inhibitor.

BI-7273
B6196-5 5 mg
EUR 168
Description: IC50: 19 and 117 nM for BRD9 and BRD7, respectively.BI-7273 is a BRD9 bromodomain inhibitor.

Mouse IgG-PE conjugate (isotype control)
20008-PE 50 Tests
EUR 164

Rabbit IgG-PE conjugate (isotype control)
20009-PE 100 tests
EUR 225

Goat IgG-PE conjugate (isotype control)
20011-PE 100 tests
EUR 225

Monoclonal Anti-Rat IgG1-PE Conjugate
50126-PE 0.1 ml
EUR 347

Goat Anti-Camel IgG-RPE conjugate
30835-RPE 0.5 ml
EUR 263

Set of 10 Biolipidure Reagents
Biolipidure-set 10mLx10
EUR 1517
Description: Set of 10 Biolipidure Reagents, whose applications include Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement

Rat IgG-PE conjugate (isotype control) (Isotype control)
20005-PE 25 tests
EUR 202

Anti-Human CD44 Monoclonal Antibody PE Conjugated, Flow Validated
FC00052-PE 25 Tests, 100 Tests, 200 Tests
EUR 153
Description: Mouse Monoclonal Human CD44 Antibody PE Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Human CD28 Monoclonal Antibody PE Conjugated, Flow Validated
FC00065-PE 25 tests, 100 tests
EUR 143
Description: Mouse Monoclonal Human CD28 Antibody PE Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Human CD40 Monoclonal Antibody PE Conjugated, Flow Validated
FC00068-PE 25 Tests, 100 Tests, 200 Tests
EUR 149
Description: Anti-Human CD40 Monoclonal Antibody PE Conjugated, Flow Validated

Anti-human CD14 Monoclonal Antibody PE Conjugated, Flow Validated
FC00137-PE 25 Tests, 100 Tests, 200 Tests
EUR 153
Description: Mouse Monoclonal human CD14 Antibody PE Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD11b Monoclonal Antibody PE Conjugated, Flow Validated
FC00144-PE 25 Tests, 100 Tests, 200 Tests
EUR 153
Description: Mouse Monoclonal human CD11b Antibody PE Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD19 Monoclonal Antibody PE Conjugated, Flow Validated
FC00154-PE 25 Tests, 100 Tests, 200 Tests
EUR 108
Description: Mouse Monoclonal human CD19 Antibody PE Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Human CD54 Monoclonal Antibody PE Conjugated, Flow Validated
FC00171-PE 25 Tests, 100 Tests, 200 Tests
EUR 142
Description: Anti-Human CD54 Monoclonal Antibody PE Conjugated, Flow Validated

Anti-human CD38 Monoclonal Antibody PE Conjugated, Flow Validated
FC00193-PE 25 Tests, 100 Tests, 200 Tests
EUR 153
Description: Mouse Monoclonal human CD38 Antibody PE Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD25 Monoclonal Antibody PE Conjugated, Flow Validated
FC00214-PE 25 Tests, 100 Tests, 200 Tests
EUR 125
Description: Mouse Monoclonal human CD25 Antibody PE Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Human CD86 Monoclonal Antibody PE Conjugated, Flow Validated
FC00220-PE 25 Tests, 100 Tests, 200 Tests
EUR 153
Description: Mouse Monoclonal Human CD86 Antibody PE Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD4 Monoclonal Antibody PE Conjugated, Flow Validated
FC00344-PE 25 Tests, 100 Tests, 200 Tests
EUR 113
Description: Mouse Monoclonal human CD4 Antibody PE Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Human CD11c Monoclonal Antibody PE Conjugated, Flow Validated
FC00357-PE 25 Tests
EUR 136
Description: Mouse Monoclonal Human CD11c Antibody PE Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD5 Monoclonal Antibody PE Conjugated, Flow Validated
FC00480-PE 25 Tests, 100 Tests, 200 Tests
EUR 153
Description: Mouse Monoclonal Anti-human CD5 PE Conjugated, designed for Flow Cytometry and validated by Flow Cytometry using Human cells.

Comparative analysis between a medical system and regent dipsticks in measuring pH

Targets: Urinary pH is a decisive take into consideration plenty of pathologies, there by an informative marker employed in remedy selections. Although extensively used, the urinary pH dipstick check out won’t be sufficiently right or actual for scientific selections and additional sturdy methodologies must be considered. On this analysis, we consider pH measurements when using aportable medical system and completely completely different dipstick exams.
Provides and techniques:Four pH dipstick producers and a Lit-Administration® pH Meter had been examined using enterprise buffer choices with seven distinct pH values representing the physiological differ in urine (4.66; 5.0;5.5; 6.0; 7.0; 7.5; 8.0). A statistical analysis was carried out to guage the correlation of measured versus precise values, together with validity measures as resolution,precision and accuracy.
Outcomes: Validity measures stated the prevalence of the moveable pH meter, with a decreased dispersion of data and additional precise values. Furthermore, correlation analysis reveal that the pH values obtained with the pH meter had been the closest to the buffers’ precise pH values.
Conclusion: The detailed comparative analysis launched proper right here reveal the prevalence of a conveyable pH meter to plenty of of primarily essentially the most used dipstick producers inside the clinic.Lit-Administration® pH Meter represents a reliable completely different when a monitoring of urinary pH is required, as may happen in the middle of the screening of illnesses or remedy monitoringin the clinic, along with in the middle of the self-monitoringby the affected particular person beneath expert supervision at dwelling.
Objetivos: El pH urinario es un subject decisivo en varias patologías, en consecuencia, un marcador informativo empleado en las decisiones de tratamiento. Aunque ampliamente utilizada, la tira reactiva puede no ser lo suficientemente acurada o precisa para la toma de decisiones clínicas y otras metodologías más robustas deben ser consideradas.

En este estudio,comparamos las mediciones de pH cuando usamos un dispositivo médico portátil y diferentes tiras reactivas.

MATERIALES Y MÉTODOS: Se probaron cuatro marcas de tiras reactives de pH y un medidor de pH, Lit-Administration® pH Meter, utilizando soluciones tampón comerciales con siete valores de pH distintos que representan el rango fisiológico de pH en orina (4.66; 5.0; 5.5; 6.0;7.0; 7.5; 8.0). Se realizó un análisis estadístico para evaluar la correlación de los valores medidos versus los reales, junto con las medidas de validez como resolución,precisión y exactitud.

Resultados: Las medidas de validez indicaron la superioridad del medidor de pH portátil, con una reducción de la dispersión de los datos y valores más exactos. Además, el análisis de correlación demuestra que los valores de pH obtenidos con el medidor de pH fueron los más cercanos a los valores de pH reales de los tampones.

CONCLUSIÓN: El estudio comparativo detallado presentado aquí revela la superioridad de un medidor portátil de pH frente algunas de las marcas comerciales de tiras reactivas más ampliamente usadas en las práctica clínica. El Lit-Administration® pH Meter representa una alternativa fiable cuando se necesita un monitoreo del pH urinario, como puede suceder durante la detección de enfermedades o la monitorización del tratamiento a nivel clínico, así como durante el autocontrol domiciliario del paciente, bajo supervisión profesional.

Key phrases: Cálculos renales; Dispositivo médico; Kidney stones; Lithiasis; Litiasis; Medical system; Medidor de pH; Urinary pH; Urolithiasis; Urolitiasis; pH meter; pH urinario.

CD26 antibody (FITC)
61R-CD26aHUFT 120 tests
EUR 413
Description: Mouse monoclonal CD26 antibody (FITC)

Dipeptidyl Peptidase 4 (CD26) Antibody (RPE)
abx412944-100tests 100 tests
EUR 592

Dipeptidyl Peptidase 4 (CD26) Antibody (RPE)
abx414068-100tests 100 tests
EUR 592

Dipeptidyl Peptidase 4 (CD26) Antibody (RPE)
abx414069-25tests 25 tests
EUR 314

Anti-Hu CD26 FITC
1F-608-T025 25 tests
EUR 122

Anti-Hu CD26 FITC
1F-608-T100 100 tests
EUR 204

anti- SR-BI antibody
FNab08215 100µg
EUR 548.75
Description: Antibody raised against SR-BI

EZ-DNA Reagents
BS8202 100preps
EUR 88.06

EZ-DNA Reagents
SK8201 100preps
EUR 93.5

Mouse Anti Human Cd26 Monoclonal Antibody,RPE
CABT-45831MH 100 TEST
EUR 710

Rat Anti Mouse Cd26 Monoclonal Antibody,RPE
CABT-45844RM 100 TEST
EUR 533

Dipeptidyl Peptidase 4 (CD26) Antibody (PE)
abx200203-100tests 100 tests
EUR 453

Dipeptidyl Peptidase 4 (CD26) Antibody (PE)
abx139398-100tests 100 tests
EUR 481

BI 6727
2222-1
EUR 120

BI 6727
2222-5
EUR 327

BI-2536
2370-25
EUR 523

BI-2536
2370-5
EUR 175

BI-D1870
1924-1
EUR 142

BI-D1870
1924-5
EUR 370

BI-78D3
B1686-25
EUR 528

BI-78D3
B1686-5
EUR 175

BI-7273
B1879-25
EUR 892

BI-7273
B1879-5
EUR 262

BI-9564
B1880-25
EUR 756

BI-9564
B1880-5
EUR 229

BI-409306
B2377-25
EUR 756

BI-409306
B2377-5
EUR 229

BI-7273
HY-100351 50mg
EUR 877

BI-9564
HY-100352 200mg
EUR 2254

BI 689648
HY-101217 25mg
EUR 2116

BI-78D3
HY-10366 25mg
EUR 349

BI-6C9
HY-103661 50mg
EUR 1083

BI-D1870
HY-10510 2mg
EUR 147

BI-882370
HY-107779 100mg
EUR 1164

BI-3802
HY-108705 10mg
EUR 911

BI-3812
HY-111381 25mg
EUR 1772

BI-3663
HY-111546 1mg
EUR 681

BI-749327
HY-111925 100mg
EUR 3092

BI-409306
HY-112831 50mg
EUR 2058

BI-671800
HY-114141 100mg
EUR 3092

BI-1347
HY-120350 10mM/1mL
EUR 176

BI-167107
HY-121251 100mg
EUR 2633

BI-4464
HY-124625 10mg
EUR 911

BI 01383298
HY-124738 10mM/1mL
EUR 163

BI-4020
HY-129550 10mg
EUR 681

BI-9627
HY-18071 5mg
EUR 291

BI 224436
HY-18595 5mg
EUR 533

(±)-BI-D
HY-18601 100mg
EUR 2943

BI-847325
HY-18955 100mg
EUR 1262

BI 2536
HY-50698 100mg
EUR 1229

BI-D1870
B2227-10 10 mg
EUR 270
Description: BI-D1870 is a cell-permeable inhibitor of the p90 RSK isoforms with IC50 values of 31nM, 24nM, 18nM and 15nM for RSK1, RSK2, RSK3 and RSK4 respectively [1].BI-D1870 is a derivative of dihydropteridinone and found to be a remarkably specific inhibitor of RSK isoforms.

BI-D1870
B2227-5 5 mg
EUR 189
Description: BI-D1870 is a cell-permeable inhibitor of the p90 RSK isoforms with IC50 values of 31nM, 24nM, 18nM and 15nM for RSK1, RSK2, RSK3 and RSK4 respectively [1].BI-D1870 is a derivative of dihydropteridinone and found to be a remarkably specific inhibitor of RSK isoforms.

BI-D1870
B2227-5.1 10 mM (in 1mL DMSO)
EUR 235
Description: BI-D1870 is a cell-permeable inhibitor of the p90 RSK isoforms with IC50 values of 31nM, 24nM, 18nM and 15nM for RSK1, RSK2, RSK3 and RSK4 respectively [1].BI-D1870 is a derivative of dihydropteridinone and found to be a remarkably specific inhibitor of RSK isoforms.

BI-D1870
B2227-50 50 mg
EUR 595
Description: BI-D1870 is a cell-permeable inhibitor of the p90 RSK isoforms with IC50 values of 31nM, 24nM, 18nM and 15nM for RSK1, RSK2, RSK3 and RSK4 respectively [1].BI-D1870 is a derivative of dihydropteridinone and found to be a remarkably specific inhibitor of RSK isoforms.

BI 6015
B5668-10 10 mg
EUR 179
Description: BI 6015 is an antagonist of hepatocyte nuclear factor 4? [1]. Hepatocyte nuclear factor 4? (HNF4?) is a nuclear receptor and regulates gene expression in enterocytes, hepatocytes and pancreatic ? cells [1]. BI 6015 is a HNF4? antagonist.

BI 6015
B5668-5 5 mg
EUR 118
Description: BI 6015 is an antagonist of hepatocyte nuclear factor 4? [1]. Hepatocyte nuclear factor 4? (HNF4?) is a nuclear receptor and regulates gene expression in enterocytes, hepatocytes and pancreatic ? cells [1]. BI 6015 is a HNF4? antagonist.

BI 6015
B5668-50 50 mg
EUR 595
Description: BI 6015 is an antagonist of hepatocyte nuclear factor 4? [1]. Hepatocyte nuclear factor 4? (HNF4?) is a nuclear receptor and regulates gene expression in enterocytes, hepatocytes and pancreatic ? cells [1]. BI 6015 is a HNF4? antagonist.

BI-847325
B6014-1 1 mg
EUR 132
Description: BI 847325 is a dual inhibitor of Ras-mitogen-activated protein kinase kinases (MEK) and Aurora kinases [1,2]. BI 847325 inhibits MEK1 and MEK2 with IC50 values of 25 and 4 nM, respectively.

BI-847325
B6014-5 5 mg
EUR 242
Description: BI 847325 is a dual inhibitor of Ras-mitogen-activated protein kinase kinases (MEK) and Aurora kinases [1,2]. BI 847325 inhibits MEK1 and MEK2 with IC50 values of 25 and 4 nM, respectively.

BI-9564
B6184-1 1 mg
EUR 109
Description: IC50: 75 nM and 3.4 ?M for BRD9 and BRD7 bromodomains, respectivelyBI-9564 is a BRD9/7 specific inhibitor.BRD7 and BRD9 are two important members of the bromodomain family protein.

BI-9564
B6184-10 10 mg
EUR 293
Description: IC50: 75 nM and 3.4 ?M for BRD9 and BRD7 bromodomains, respectivelyBI-9564 is a BRD9/7 specific inhibitor.BRD7 and BRD9 are two important members of the bromodomain family protein.

BI-7273
B6196-25 25 mg
EUR 437
Description: IC50: 19 and 117 nM for BRD9 and BRD7, respectively.BI-7273 is a BRD9 bromodomain inhibitor.

BI-7273
B6196-5 5 mg
EUR 168
Description: IC50: 19 and 117 nM for BRD9 and BRD7, respectively.BI-7273 is a BRD9 bromodomain inhibitor.

BI 2536
A3965-10 10 mg
EUR 224
Description: BI 2536 is a potent, ATP-competitive, well tolerated and highly specific human polo-like kinase 1 (PLK1) inhibitor with IC value of 0.83 nM, which shows 1000-fold selectivity against other kinases [1].

BI 2536
A3965-5 5 mg
EUR 148
Description: BI 2536 is a potent, ATP-competitive, well tolerated and highly specific human polo-like kinase 1 (PLK1) inhibitor with IC value of 0.83 nM, which shows 1000-fold selectivity against other kinases [1].

BI 2536
A3965-5.1 10 mM (in 1mL DMSO)
EUR 195
Description: BI 2536 is a potent, ATP-competitive, well tolerated and highly specific human polo-like kinase 1 (PLK1) inhibitor with IC value of 0.83 nM, which shows 1000-fold selectivity against other kinases [1].

BI 2536
A3965-50 50 mg
EUR 595
Description: BI 2536 is a potent, ATP-competitive, well tolerated and highly specific human polo-like kinase 1 (PLK1) inhibitor with IC value of 0.83 nM, which shows 1000-fold selectivity against other kinases [1].

BI 2536
A3965-S Evaluation Sample
EUR 81
Description: BI 2536 is a potent, ATP-competitive, well tolerated and highly specific human polo-like kinase 1 (PLK1) inhibitor with IC value of 0.83 nM, which shows 1000-fold selectivity against other kinases [1].

BI 78D3
B9011-10 10 mg
EUR 216
Description: BI-78D3 is a substrate competitive inhibitor of JNK inhibitor [2].JNK is a member of the MAPK family. JNK is a stress-activated protein kinase that modulates pathways implicated in a variety of disease states.

BI 78D3
B9011-100 100 mg
EUR 1094
Description: BI-78D3 is a substrate competitive inhibitor of JNK inhibitor [2].JNK is a member of the MAPK family. JNK is a stress-activated protein kinase that modulates pathways implicated in a variety of disease states.

BI 78D3
B9011-25 25 mg
EUR 412
Description: BI-78D3 is a substrate competitive inhibitor of JNK inhibitor [2].JNK is a member of the MAPK family. JNK is a stress-activated protein kinase that modulates pathways implicated in a variety of disease states.

BI 78D3
B9011-5 5 mg
EUR 161
Description: BI-78D3 is a substrate competitive inhibitor of JNK inhibitor [2].JNK is a member of the MAPK family. JNK is a stress-activated protein kinase that modulates pathways implicated in a variety of disease states.

BI 78D3
B9011-5.1 10 mM (in 1mL DMSO)
EUR 183
Description: BI-78D3 is a substrate competitive inhibitor of JNK inhibitor [2].JNK is a member of the MAPK family. JNK is a stress-activated protein kinase that modulates pathways implicated in a variety of disease states.

BI 78D3
B9011-50 50 mg
EUR 676
Description: BI-78D3 is a substrate competitive inhibitor of JNK inhibitor [2].JNK is a member of the MAPK family. JNK is a stress-activated protein kinase that modulates pathways implicated in a variety of disease states.

Goat Anti-Camel IgG-RPE conjugate
30835-RPE 0.5 ml
EUR 263

Mouse IgG-PE conjugate (isotype control)
20008-PE 50 Tests
EUR 164

Rabbit IgG-PE conjugate (isotype control)
20009-PE 100 tests
EUR 225

Goat IgG-PE conjugate (isotype control)
20011-PE 100 tests
EUR 225

Monoclonal Anti-Rat IgG1-PE Conjugate
50126-PE 0.1 ml
EUR 347

CD26
26A-100T 100 test
EUR 349

CD26
26B-01MG 100 test
EUR 284

CD26
26CFB-100T 100 test
EUR 388

CD26
26F-100T 100 test
EUR 297

CD26
26PE-100T 100 test
EUR 362

CD26
26PP-100T 100 test
EUR 415.3

CD26
26PU-01MG 0,1 mg
EUR 219

Dipeptidyl Peptidase 4 (CD26) Antibody (FITC)
abx412942-01mg 0.1 mg
EUR 509

Dipeptidyl Peptidase 4 (CD26) Antibody (FITC)
abx414066-01mg 0.1 mg
EUR 509

Dipeptidyl Peptidase 4 (CD26) Antibody (FITC)
abx200202-100tests 100 tests
EUR 398

Dipeptidyl Peptidase 4 (CD26) Antibody (FITC)
abx139400-100tests 100 tests
EUR 425

Set of 10 Biolipidure Reagents
Biolipidure-set 10mLx10
EUR 1517
Description: Set of 10 Biolipidure Reagents, whose applications include Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement

Rat IgG-PE conjugate (isotype control) (Isotype control)
20005-PE 25 tests
EUR 202

Dipeptidyl Peptidase 4 / CD26 (DPP4) Antibody (FITC)
20-abx335362
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
Tagsantibodies covid antibodies covid 19 antibodies definition antibodies fade antibodies fading antibodies for coronavirus antibodies for coronavirus immunity antibodies immunity study antibodies in blood antibodies joke antibodies medical meaning antibodies test antibodies test cost antibodies test covid antibodies test covid 19 antibodies test for coronavirus antibodies testing antibodies testing covid 19 antibodies to rbc antibodies vs t cells recombinant proteins biotechnology recombinant proteins definition recombinant proteins drug recombinant proteins examples recombinant proteins ppt recombinant proteins production recombinant proteins sds page gel recombinant proteins technology

Leave a Reply

Your email address will not be published.